Estimating individual lifetime benefit and bleeding risk with NOAC addition to asprin in stable CVD5' education - Oct. 14, 2019 - Paris, France - Tamar de Vries, MD – Utrecht, The Netherlands
In the Cardiovascular Scene Investigation (CSI) series, investigators from Utrecht report at the ESC congress, from the perspective of young investigators. They put a question to researchers about presented study results.
Tamar de Vries, MD – PhD candidate, UMC Utrecht, The Netherlands
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenters and do not necessarily reflect the views of PACE-cme.